Marin M L, Parsons R E, Hollier L H, Mitty H A, Ahn J, Parsons R E, Temudom T, D'Ayala M, McLaughlin M, DePalo L, Kahn R
Department of Surgery, The Mount Sinai School of Medicine, New York, NY, USA.
J Vasc Surg. 1998 Oct;28(4):638-46. doi: 10.1016/s0741-5214(98)70088-6.
Successful endovascular repair of an abdominal aortic aneurysm (AAA) requires the creation of a hemostatic seal between the endograft and the underlying aortic wall. A short infrarenal aortic neck may be responsible for incomplete aneurysm exclusion and procedural failure. Sixteen patients who had an endograft positioned completely below the lowest renal artery and 37 patients in whom a porous portion of an endograft attachment system was deliberately placed across the renal arteries were studied to identify if endograft positioning could impact on the occurrence of incomplete aneurysm exclusion.
Fifty-three patients underwent aortic grafting constructed from a Palmaz balloon expandable stent and an expandable polytetrafluoroethylene (ePTFE) graft implanted in an aorto-ilio-femoral, femoral-femoral configuration. Arteriography, duplex ultrasonography and spiral CT scans were performed in each patient before and after endografting to evaluate for technical success, the presence of endoleaks, and renal artery perfusion.
There was no statistically significant difference in patient demography, AAA size, or aortic neck length or diameter between patients who had their endografts placed below or across the renal arteries. However, significantly more proximal aortic endoleaks occurred in those patients with infrarenal endografts (P < or = .05). Median serum creatinine level before and after endografting was not significantly different between the 2 patient subgroups, with the exception of 2 patients who had inadvertent coverage of a single renal orifice by the endograft. Median blood pressure and the requirement for antihypertensive therapy remained the same after transrenal aortic stent grafting. Significant renal artery compromise did not occur after appropriately positioned transrenal stents as shown by means of angiography, CT scanning, and duplex ultrasound scan. Mean follow-up time was 10.3 months (range, 3 to 18 months). Patients who had significant renal artery stenosis (> or =50%) before aortic endografting did not show progression of renal artery stenosis after trans-renal endografting. Two patients with transrenal aortic stent grafts had inadvertent coverage of 1 renal artery by the endograft because of device malpositioning, which resulted in nondialysis dependent renal insufficiency. In addition, evidence of segmental renal artery infarction (<20% of the kidney), which did not result in an apparent change in renal function, was shown by means of follow-up CT scans in 2 patients with transrenal endografts.
Transrenal aortic endograft fixation using a balloon expandable device in patients with AAAs can result in a significant reduction in the risk of proximal endoleaks. Absolute attention to precise device positioning, coupled with the use of detailed imaging techniques, should reduce the risk of inadvertent renal artery occlusion from malpositioning. Long-term follow-up is essential to determine if there will be late sequelae of transrenal fixation of endografts, which could adversely effect renal perfusion.
腹主动脉瘤(AAA)的成功血管内修复需要在血管内移植物与主动脉壁之间形成止血密封。肾下腹主动脉颈短可能导致动脉瘤排除不完全和手术失败。研究了16例血管内移植物完全位于最低肾动脉下方的患者和37例血管内移植物附着系统的多孔部分故意横跨肾动脉放置的患者,以确定血管内移植物的位置是否会影响动脉瘤排除不完全的发生。
53例患者接受了由Palmaz球囊可扩张支架和可扩张聚四氟乙烯(ePTFE)移植物构建的主动脉移植,植入方式为主动脉-髂-股、股-股构型。在血管内移植前后对每位患者进行动脉造影、双功超声检查和螺旋CT扫描,以评估技术成功率、内漏情况和肾动脉灌注情况。
血管内移植物置于肾动脉下方或横跨肾动脉的患者在人口统计学、AAA大小、主动脉颈长度或直径方面无统计学显著差异。然而,肾下腹主动脉内移植物的患者近端主动脉内漏明显更多(P≤0.05)。除2例患者的肾动脉开口被血管内移植物意外覆盖外,两个患者亚组血管内移植前后的血清肌酐中位数水平无显著差异。经肾主动脉支架移植后,平均血压和抗高血压治疗需求保持不变。血管造影、CT扫描和双功超声扫描显示,适当放置经肾支架后未发生明显的肾动脉损伤。平均随访时间为10.3个月(范围3至18个月)。主动脉内移植术前有明显肾动脉狭窄(≥50%)的患者,经肾内移植后未出现肾动脉狭窄进展。2例经肾主动脉支架移植患者因装置位置不当,肾动脉被血管内移植物意外覆盖,导致非透析依赖的肾功能不全。此外,2例经肾血管内移植物患者的随访CT扫描显示有节段性肾动脉梗死(<肾脏的20%),但未导致肾功能明显改变。
在AAA患者中使用球囊可扩张装置进行经肾主动脉内移植物固定可显著降低近端内漏风险。绝对注意精确的装置定位,并结合使用详细的成像技术,应可降低因位置不当导致意外肾动脉闭塞的风险。长期随访对于确定经肾固定血管内移植物是否会有后期后遗症至关重要,这些后遗症可能对肾灌注产生不利影响。